Showing results (131-140 of 220) with videos related to
Sort By:
Pageof 22
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degenerationI Ghorayeb, P O Fernagut, I Aubert, et al.Experimental Neurology|August 1, 1995
The "campus syndrome" in pigs: neurological, neurophysiological, and neuropharmacological characterization of a new genetic animal model of high-frequency tremorA Richter, J Wissel, B Harlizius, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Slowing of high-speed memory scanning in Parkinson's disease is related to the severity of parkinsonian motor symptomsG Ransmayr, W Bitschnau, B Schmidhuber-Eiler, et al.Der Nervenarzt|December 1, 1995
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]T E Eichhorn, A Schrag, C Trenkwalder, et al.Neurology|May 20, 1998
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.Brain : a Journal of Neurology|November 5, 1999
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative studyM Reindl, C Linington, U Brehm, et al.Der Nervenarzt|April 24, 2010
[Non-motor Symptoms Questionnaire and Scale for Parkinson's disease. Cross-cultural adaptation into the German language]A Storch, P Odin, I Trender-Gerhard, et al.International Journal of Clinical Practice|September 30, 2008
Diagnosis and management of Parkinson's disease dementiaW Poewe, S Gauthier, D Aarsland, et al.Neuropsychologia|May 12, 2009
Decision making under risk and under ambiguity in Parkinson's diseaseM Delazer, H Sinz, L Zamarian, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 1, 1993
[The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test]J Hierholzer, M Cordes, L Schelosky, et al.Pageof 22